A double-blind placebo-controlled trial with loperamide in irritable bowel syndrome.

Author: BernklevT, EfskindP S, VatnM H

Paper Details 
Original Abstract of the Article :
Loperamide has a relaxing effect on localized and segmental large-bowel spasms. On the basis of previously observed effects on pain and stool habits in patients with diarrhoea, the present trial intended to examine the regulating effect in an unselected cohort of patients with the irritable bowel sy...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.3109/00365529609006766

データ提供:米国国立医学図書館(NLM)

Loperamide in Irritable Bowel Syndrome (IBS)

Irritable bowel syndrome (IBS), like a desert wind, can cause unpredictable and uncomfortable digestive disturbances. This study investigates the potential of loperamide, a medication known for its anti-diarrheal effects, in managing IBS. The authors conducted a double-blind, placebo-controlled trial to evaluate the effects of loperamide on IBS symptoms in an unselected cohort of patients. The results of this study explore the role of loperamide in regulating bowel motility, offering insights into its potential as a therapeutic option for IBS.

Understanding the Complexity of IBS

The findings of this study contribute to our understanding of the complex interplay between bowel motility and IBS symptoms. This research is like a compass guiding us through the intricate maze of IBS, helping us to identify potential therapeutic targets.

Navigating IBS with Loperamide

This study offers valuable information for clinicians managing IBS patients, providing insights into the potential benefits of loperamide. It's like a wellspring of knowledge, offering hope for patients seeking relief from their symptoms.

Dr.Camel's Conclusion

This study, like a lone traveler crossing a vast desert, ventures into the complexities of IBS, exploring the potential of loperamide as a therapeutic option.

Date :
  1. Date Completed 1996-10-09
  2. Date Revised 2022-04-09
Further Info :

Pubmed ID

8734343

DOI: Digital Object Identifier

10.3109/00365529609006766

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.